Abeona Therapeutics

Abeona Therapeutics

ABEO· Manufacturing· Fiscal year ends in December

CEO pay in FY2025Stock -5.4% in FY2025

Vishwas Seshadri is the CEO of Abeona Therapeutics and was paid $4.0M in FY2025 (Dec), up 14%.

Pay$100 in the stock at the end of FY21 → $63
CEO pay is from each Abeona Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Executives3

See all
  1. 1Vishwas SeshadriFY2025
  2. 2Joseph VazzanoFY2025
  3. 3Brendan O’MalleyFY2025

Named executives and their total pay, from the Summary Compensation Table of the latest proxy.

Pay

See all

Abeona Therapeutics paid its 3 named executives $7.1M in total in FY2025 (Dec). CEO Vishwas Seshadri was paid $4.0M of that.

Name
Vishwas SeshadriPresident and Chief Executive Officer
Joseph VazzanoChief Financial Officer
Brendan O’MalleyChief Legal Officer

of each named executive, from the Summary Compensation Table of each proxy.

Peers

No disclosed peer group

No proxy on file names a pay peer group for Abeona Therapeutics. The peer group comes from the proxy statement, so it shows here when a proxy read has it.

Board1

See all
  • Michael AmorosoChair · 4 yr on the boardIndependentNominating and Corporate Governance—Paid as an executive

The board of the latest proxy (FY2025).

Activity

Filings6

See all
Proxy statementDEF 14AApr 27, 2026FY2025
Annual report10-KMar 17, 2026FY2025
Proxy statementDEF 14AApr 9, 2025FY2024
Annual report10-KMar 20, 2025FY2024
Proxy statementDEF 14AMar 19, 2024FY2023
Annual report10-KMar 18, 2024FY2023
For the press:Download CSVDownload PNGHow to use our data